Market By Systems, Applications, And Geography | Forecast 2019-2027
The Latin America neurostimulation device market is estimated to grow at a CAGR of 10.55% for the forecasting years 2019-2027.
The countries analyzed in the neurostimulation device market in the Latin American region are:
• Brazil
• Mexico
• Rest of Latin America
The governments of Latin America have been investing significantly to promote research in Alzheimer’s disease and dementia to deliver new neurological devices. For instance, the Alzheimer’s Association has invested around $84 million in 400 active projects in Latin American countries. The primary objective of this investment is to provide new and advanced devices to treat neurological disorders like Alzheimer’s and dementia. This would help in boosting the growth of the neurostimulation device market in the region.
Report scope can be customized per your requirements. Request For Customization
There is a high mortality rate in Brazil due to Alzheimer’s disease, which is expected to increase the demand for neurostimulation devices as these devices are highly used to treat patients with any neurological disorders. The Brazilian government has also introduced several healthcare programs and policies in order to promote the physical, mental, and social wellbeing of elderly people. Although the market for the diagnosis of Alzheimer’s disease in Brazil is highly underdeveloped, there is a huge potential to witness significant growth by the end of the forecasting years. For example, the Brazilian Alzheimer’s Association (ABRAz) provides support to families that are suffering from dementia. Additionally, many private healthcare insurance providers are providing their assistance for eldercare to senior citizens. These initiatives are expected to fuel the adoption of neurostimulation devices to treat patients by offering physical therapies and training that will help to reduce the recovery period.
DePuy Synthes Companies is a franchise of neurosurgery and orthopedic companies. The company develops and markets various products under brands such as DePuy Mitek, DePuy Orthopedic, DePuy spine, and Codman. The products under DePuy Spine facilitate fusion of spine & correction of spinal deformities, preserve motion of the spine, and repair bone fractures. The company has its presence globally, including regions such as North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA NEUROSTIMULATION DEVICE MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF SUPPLIERS
2.2.4. BARGAINING
POWER OF BUYERS
2.2.5. THREAT
OF RIVALRY
2.3. VALUE
CHAIN OUTLOOK
2.4. MARKET
TRENDS
2.5. MARKET
SHARE OUTLOOK
2.6. PESTLE
OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. RISING
INCIDENCE OF NEURO DISEASES
2.9.2. INCREASING
GERIATRIC POPULATION
2.9.3. GROWING
DEMAND FOR MRI SCANS
2.10.
MARKET RESTRAINTS
2.10.1.
HIGH COST OF NEUROMODULATION TREATMENT
2.10.2.
PRESENCE OF ALTERNATIVE THERAPY
2.11.
MARKET OPPORTUNITIES
2.11.1.
HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION
2.11.2.
TECHNOLOGICAL DEVELOPMENT
2.11.3.
GROWING INCIDENCE OF CHRONIC DISCOMFORT
2.12.
MARKET CHALLENGES
2.12.1.
STRINGENT REGULATORY APPROVALS
2.12.2.
SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION
DEVICES
3. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY SYSTEMS
3.1. SPINAL
CORD STIMULATORS (SCS)
3.2. DEEP
BRAIN STIMULATORS (DBS)
3.3. SACRAL
NERVE STIMULATORS (SNS)
3.4. VAGUS
NERVE STIMULATORS (VNS)
3.5. GASTRIC
ELECTRIC STIMULATOR
3.6. OTHER
SYSTEM
4. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY APPLICATIONS
4.1. PAIN
MANAGEMENT
4.2. EPILEPSY
4.3. ESSENTIAL
TREMOR
4.4. URINARY
AND FECAL INCONTINENCE
4.5. DEPRESSION
4.6. DYSTONIA
4.7. GASTROPARESIS
4.8. PARKINSON’S
DISEASE
4.9. OTHER
APPLICATIONS
5. NEUROSTIMULATION
DEVICE MARKET – REGIONAL OUTLOOK
5.1.1. COUNTRY
ANALYSIS
5.1.1.1. BRAZIL
5.1.1.2. MEXICO
5.1.1.3. REST
OF LATIN AMERICA
6. COMPANY
PROFILES
6.1. NEURONETICS,
INC.
6.2. ST.
JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)
6.3. HOCOMA
AG
6.4. NEVRO
CORP.
6.5. CYBERONICS
INC.
6.6. COGENTIX
MEDICAL, INC.
6.7. DEPUY
SYNTHES COMPANIES
6.8. DR.
LANGER MEDICAL GMBH
6.9. MEDTRONIC
PLC
6.10.
THE MAGSTIM COMPANY LIMITED
6.11.
ECTRON LIMITED
6.12.
BOSTON SCIENTIFIC CORPORATION
6.13.
EKSO BIONICS HOLDING INC.
6.14.
ALEVA NEUROTHERAPEUTICS SA
6.15.
HELIUS MEDICAL TECHNOLOGIES
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($
MILLION)
TABLE 2 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM
2019-2027 ($ MILLION)
TABLE 3 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS
2019-2027 ($ MILLION)
TABLE 4 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY
2019-2027 ($ MILLION)
FIGURE 1 LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET 2019-2027 ($ MILLION)
FIGURE 2 VALUE CHAIN OUTLOOK
FIGURE 3 NEUROSTIMULATION DEVICE COMPANY MARKET
SHARE OUTLOOK 2018 (%)
FIGURE 4 LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)
FIGURE 5 LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)
FIGURE 6 LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 7 LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 8 LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)
FIGURE 9 LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)
FIGURE 10 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY PAIN MANAGEMENT 2019-2027 ($ MILLION)
FIGURE 11 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY EPILEPSY 2019-2027 ($ MILLION)
FIGURE 12 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)
FIGURE 13 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)
FIGURE 14 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY DEPRESSION 2019-2027 ($ MILLION)
FIGURE 15 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY DYSTONIA 2019-2027 ($ MILLION)
FIGURE 16 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY GASTROPARESIS 2019-2027 ($ MILLION)
FIGURE 17 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)
FIGURE 18 LATIN AMERICA NEUROSTIMULATION DEVICE MARKET
BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 19 BRAZIL NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 20 MEXICO NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 21 REST OF LATIN AMERICA NEUROSTIMULATION DEVICE
MARKET 2019-2027 ($ MILLION)